|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM372864201 |
003 |
DE-627 |
005 |
20240711232304.0 |
007 |
cr uuu---uuuuu |
008 |
240527s2024 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1111/jfd.13964
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1467.xml
|
035 |
|
|
|a (DE-627)NLM372864201
|
035 |
|
|
|a (NLM)38798108
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Lan, Nguyen Giang Thu
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Review of current perspectives and future outlook on bacterial disease prevention through vaccination in Asian seabass (Lates calcarifer)
|
264 |
|
1 |
|c 2024
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 10.07.2024
|
500 |
|
|
|a Date Revised 10.07.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2024 John Wiley & Sons Ltd.
|
520 |
|
|
|a Asian seabass, Lates calcarifer, is an important aquatic species in mariculture. Intensive farming of this species has faced episodes of bacterial diseases, including those due to vibriosis, scale drop, and muscle necrosis disease, big belly disease, photobacteriosis, columnaris, streptococcosis, aeromoniasis, and tenacibaculosis. Vaccination is one of the most efficient, non-antibiotic, and eco-friendly strategies for protecting fish against bacterial diseases, contributing to aquaculture expansion and ensuring food security. As of now, although numerous vaccines have undergone laboratory research, only one commercially available inactivated vaccine, suitable for both immersion and injection administration, is accessible for preventing Streptococcus iniae. Several key challenges in developing vaccines for Asian seabass must be addressed, such as the current limited understanding of immunological responses to vaccines, the costs associated with vaccine production, forms, and routes of vaccine application, and how to increase the adoption of vaccines by farmers. The future of vaccine development for the Asian seabass industry, therefore, is discussed with these key critical issues in mind. The focus is on improving our understanding of Asian seabass immunity, including maternal immunity, immunocompetence, and immune responses post-vaccination, as well as developing tools to assess vaccine effectiveness. The need for an alignment of fish vaccines with state-of-the-art vaccine technologies employed in human and terrestrial animal healthcare is also discussed. This review also discusses the necessity of providing locally-produced autogenous vaccines, especially for immersion and oral vaccines, to benefit small-scale fish farmers, and the potential benefits that might be extended through changes to current husbandry practices such as the vaccination of broodstock and earlier life stages of their off-spring
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Review
|
650 |
|
4 |
|a Asian seabass
|
650 |
|
4 |
|a antibody response
|
650 |
|
4 |
|a bacterial diseases
|
650 |
|
4 |
|a vaccines
|
650 |
|
7 |
|a Bacterial Vaccines
|2 NLM
|
700 |
1 |
|
|a Dong, Ha Thanh
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Shinn, Andrew P
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Vinh, Nguyen Tien
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Senapin, Saengchan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Salin, Krishna R
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Rodkhum, Channarong
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Journal of fish diseases
|d 1998
|g 47(2024), 8 vom: 31. Juli, Seite e13964
|w (DE-627)NLM098166034
|x 1365-2761
|7 nnns
|
773 |
1 |
8 |
|g volume:47
|g year:2024
|g number:8
|g day:31
|g month:07
|g pages:e13964
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1111/jfd.13964
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 47
|j 2024
|e 8
|b 31
|c 07
|h e13964
|